INAB

IN8BIO INC

INAB·45674E208·US·Common Stock·Healthcare - Biotechnology-Activist

INAB (IN8BIO INC) is held by 15 institutional investors as of Q2 2026. Largest holders: Alyeska Investment Group, L.P. ($1.3M), FRANKLIN RESOURCES INC ($1.3M), VANGUARD CAPITAL MANAGEMENT LLC ($126,544). Net institutional sentiment: Mixed.

15
Holders
(2 Elite)
$3.1M
Total Value
57% (7)
Consensus
4 buying - 3 selling
13F: Insider & Congress: Updated regularly
INAB

Smart Money Verdict

View all
Loading verdict
Held by 15 funds
2 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists Aug 13, 2026 · Congress none

ActivistLLLYTTON LAURENCE W10.0%Aug 13, 2026
ActivistEFEMILY FAIRBAIRN2.2%May 29, 2026
ActivistLLLYTTON LAURENCE W10.0%Mar 2, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
944,319$1.3M0.0%-60.96%
0
Unchanged
914,531$1.3M0.0%-66.35%
0
Unchanged
88,865$126,5440.0%-31.10%
0
Decreased
72,550(-15.9%)$102,2980.0%-84.03%
0
New
63,055$88,9080.0%-15.96%
33
Unchanged
43,570$62,0440.0%-31.10%
0
Unchanged
33,295$46,9460.0%-42.34%
0
Increased
21,734(+6.3%)$30,6450.0%-45.89%
14
New
12,100$17,0610.0%-15.96%
28
Unchanged
2,785$3,9270.0%-79.85%
0
Unchanged
768$1,0440.0%-49.14%
0
Unchanged
84$1180.0%-85.32%
0
Unchanged
83$1170.0%-47.57%
0
New
28$390.0%-15.96%
17
Decreased
1(-99.8%)$10.0%-51.54%
0
Exited
0(-100.0%)$18,4010.0%-38.12%
0
INABINABIN8BIO INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used